ENG
ESP
Humoral immune response induced by influenza vaccine in children with acute lymphoblastic leukemia
Published 2020-05-17
Keywords
How to Cite
Copyright (c) 2020 Constanza Pamela Martinez Valdebenito, Carolina Cerda, Francisco Barriga, Marcela Contreras, Marcela Vidal, Rosa Moreno, Ximena Claverie, Paula Contreras, Leslie Huenuman, Tamara Garcia-Salum, Raveen rathnasinghe, Rafael Medina, Marcela Ferres, Nicole Le Corre
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: Patients with acute lymphoblastic leukemia (ALL) have high risk of severe influenza infection and vaccination is highly recommended. The immunogenicity and effectiveness of vaccination are lower than in healthy people.
Aim: To evaluate the immune response induced by influenza vaccine in children with ALL and observe effectiveness.
Method: Children with ALL in maintenance phase and healthy children were recruited. Blood samples were taken at vaccination day (D0) and at day 28 (D28). Humoral response was evaluated by hemaglutination inhibition test (HAI) against H1N1. Patients were followed up for one year, clinical data and influenza episodes were recorded.
Results: 34 children with ALL and 9 healthy children were included. Concerning HAI on D28, 12/34 patients and 5/8 healthy children had titers ≥ 1/40, with seroprotection rates of 35 and 63% respectively. Seroprotected children were older than non-seroprotected ones. During follow-up, only 3 patients non seroprotected, presented influenza infection, without oxygen supplementation or critical care support.
Discussion: Children with ALL had a lower seroprotection rate than healthy children. Nevertheless, none of the seroprotected children presented influenza infection, reinforcing the annual vaccination recommendation.